Showing results (71-80 of 79) with videos related to
Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Cancer Discovery|October 10, 2019
PTEN Loss Mediates Clinical Cross-Resistance to CDK4/6 and PI3Kα Inhibitors in Breast CancerCarlotta Costa, Ye Wang, Amy Ly, et al.Molecular Cell|May 25, 2022
ARAF protein kinase activates RAS by antagonizing its binding to RASGAP NF1Wenjing Su, Radha Mukherjee, Rona Yaeger, et al.Nature Medicine|September 16, 2024
ctDNA-based molecular residual disease and survival in resectable colorectal cancerYoshiaki Nakamura, Jun Watanabe, Naoya Akazawa, et al.Oncotarget|May 4, 2017
A systematic review and meta-analysis of individual patient data on the impact of the BIM deletion polymorphism on treatment outcomes in epidermal growth factor receptor mutant lung cancerSheila X Soh, Fahad J Siddiqui, John C Allen, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 21, 2017
Epithelial-to-Mesenchymal Transition Antagonizes Response to Targeted Therapies in Lung Cancer by Suppressing BIMKyung-A Song, Matthew J Niederst, Timothy L Lochmann, et al.Proceedings of the National Academy of Sciences of the United States of America|March 5, 2015
Assessment of ABT-263 activity across a cancer cell line collection leads to a potent combination therapy for small-cell lung cancerAnthony C Faber, Anna F Farago, Carlotta Costa, et al.Nature|March 20, 2012
A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic responseZhao Chen, Katherine Cheng, Zandra Walton, et al.Nature Communications|November 5, 2025
Targeting SUMOylation promotes cBAF complex stabilization and disruption of the SS18::SSX transcriptome in synovial sarcomaKonstantinos V Floros, Carter K Fairchild, Jinxiu Li, et al.Nature Communications|June 26, 2020
Genome-wide association meta-analysis identifies GP2 gene risk variants for pancreatic cancerYingsong Lin, Masahiro Nakatochi, Yasuyuki Hosono, et al.Pageof 8